Osteosclerosis owing to Notch gain of function is solely Rbpj-dependent
Open Access
- 30 April 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 25 (10), 2175-2183
- https://doi.org/10.1002/jbmr.115
Abstract
Osteosclerosis is a pathologic bone disease characterized by an increase in bone formation over bone resorption. Genetic factors that contribute to the pathogenesis of this disease are poorly understood. Dysregulation or mutation in many components of the Notch signaling pathway results in a wide range of human developmental disorders and cancers, including bone diseases. Our previous study found that activation of the Notch signaling in osteoblasts promotes cell proliferation and inhibits differentiation, leading to an osteosclerotic phenotype in transgenic mice. In this study we report a longer‐lived mouse model that also develops osteosclerosis and a genetic manipulation that completely rescues the phenotype. Conditionally cre‐activated expression of Notch1 intracellular domain (NICD) in vivo exclusively in committed osteoblasts caused massive osteosclerosis with growth retardation and abnormal vertebrae. Importantly, selective deletion of a Notch nuclear effector—Rbpj—in osteoblasts completely suppressed the osteosclerotic and growth‐retardation phenotypes. Furthermore, cellular and molecular analyses of bones from the rescued mice confirmed that NICD‐dependent molecular alterations in osteoblasts were completely reversed by removal of the Rbpj pathway. Together, our observations show that the osteosclerosis owing to activation of Notch signaling in osteoblasts is canonical in nature because it depends solely on Rbpj signaling. As such, it identifies Rbpj as a specific target for manipulating Notch signaling in a cell‐autonomous fashion in osteoblasts in bone diseases where Notch may be dysregulated. © 2010 American Society for Bone and Mineral Research.Keywords
This publication has 54 references indexed in Scilit:
- Alteration of Notch signaling in skeletal development and diseaseAnnals of the New York Academy of Sciences, 2010
- Direct inhibition of the NOTCH transcription factor complexNature, 2009
- Inhibition of Notch pathway prevents osteosarcoma growth by cell cycle regulationBritish Journal of Cancer, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Notch signaling contributes to the pathogenesis of human osteosarcomasHuman Molecular Genetics, 2009
- Signaling cross-talk between TGF-β/BMP and other pathwaysCell Research, 2008
- Osteosarcoma Development and Stem Cell DifferentiationClinical Orthopaedics and Related Research, 2008
- Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiationNature Medicine, 2008
- Dimorphic effects of Notch signaling in bone homeostasisNature Medicine, 2008
- Abnormal vertebral segmentation and the notch signaling pathway in manDevelopmental Dynamics, 2007